Published in Lancet on February 07, 2004
Age distributions, birth weights, nephrogenic rests, and heterogeneity in the pathogenesis of Wilms tumor. Pediatr Blood Cancer (2006) 1.74
WT1 mutation and 11P15 loss of heterozygosity predict relapse in very low-risk wilms tumors treated with surgery alone: a children's oncology group study. J Clin Oncol (2010) 1.55
Children's Oncology Group's 2013 blueprint for research: renal tumors. Pediatr Blood Cancer (2012) 1.32
Clinically relevant subsets identified by gene expression patterns support a revised ontogenic model of Wilms tumor: a Children's Oncology Group Study. Neoplasia (2012) 1.19
Control of carry-over contamination for PCR-based DNA methylation quantification using bisulfite treated DNA. Nucleic Acids Res (2006) 1.17
Genetic and epigenetic alterations on the short arm of chromosome 11 are involved in a majority of sporadic Wilms' tumours. Br J Cancer (2006) 1.01
Loss of imprinting of IGF2 correlates with hypermethylation of the H19 differentially methylated region in hepatoblastoma. Br J Cancer (2008) 1.00
Perilobar nephrogenic rests are nonobligate molecular genetic precursor lesions of insulin-like growth factor-II-associated Wilms tumors. Clin Cancer Res (2008) 0.96
Stratification of Wilms tumor by genetic and epigenetic analysis. Oncotarget (2012) 0.95
Selective methylation of CpGs at regulatory binding sites controls NNAT expression in Wilms tumors. PLoS One (2013) 0.92
Social and biological factors influencing the outcomes of children with Wilms tumors in Kenya and other Sub-Saharan countries. Transl Pediatr (2014) 0.81
Wilms' tumor: biology, diagnosis and treatment. Transl Pediatr (2014) 0.81
Loss of heterozygosity at 11p13 and 11p15 in Wilms tumor: a study of 22 cases from India. Pediatr Surg Int (2013) 0.79
A high incidence of WT1 abnormality in bilateral Wilms tumours in Japan, and the penetrance rates in children with WT1 germline mutation. Br J Cancer (2015) 0.75
Addition of ifosfamide and etoposide to standard chemotherapy for Ewing's sarcoma and primitive neuroectodermal tumor of bone. N Engl J Med (2003) 8.48
Study design and cohort characteristics of the Childhood Cancer Survivor Study: a multi-institutional collaborative project. Med Pediatr Oncol (2002) 8.03
Sudden infant death syndrome and unclassified sudden infant deaths: a definitional and diagnostic approach. Pediatrics (2004) 3.02
Breast cancer in female survivors of Wilms tumor: a report from the national Wilms tumor late effects study. Cancer (2014) 2.94
Beckwith-Wiedemann syndrome. Eur J Hum Genet (2010) 2.85
Physiological functions of imprinted genes. J Cell Physiol (2002) 2.58
POU5F1 (OCT3/4) identifies cells with pluripotent potential in human germ cell tumors. Cancer Res (2003) 2.45
Pregnancy outcome after treatment for Wilms tumor: a report from the National Wilms Tumor Study Group. J Clin Oncol (2002) 2.35
Gain of 1q is associated with inferior event-free and overall survival in patients with favorable histology Wilms tumor: a report from the Children's Oncology Group. Cancer (2013) 2.32
Loss of heterozygosity for chromosomes 1p and 16q is an adverse prognostic factor in favorable-histology Wilms tumor: a report from the National Wilms Tumor Study Group. J Clin Oncol (2005) 2.28
Short sleep duration in middle childhood: risk factors and consequences. Sleep (2008) 2.19
Treatment of anaplastic histology Wilms' tumor: results from the fifth National Wilms' Tumor Study. J Clin Oncol (2006) 2.15
Integrated genetic and epigenetic analysis identifies haplotype-specific methylation in the FTO type 2 diabetes and obesity susceptibility locus. PLoS One (2010) 1.93
EdU, a new thymidine analogue for labelling proliferating cells in the nervous system. J Neurosci Methods (2008) 1.91
Myogenesis in Wilms' tumors is associated with mutations of the WT1 gene and activation of Bcl-2 and the Wnt signaling pathway. Pediatr Dev Pathol (2004) 1.89
Multiple gene expression classifiers from different array platforms predict poor prognosis of colorectal cancer. Clin Cancer Res (2007) 1.89
Age distributions, birth weights, nephrogenic rests, and heterogeneity in the pathogenesis of Wilms tumor. Pediatr Blood Cancer (2006) 1.74
Immunohistochemical analysis of hSNF5/INI1 distinguishes renal and extra-renal malignant rhabdoid tumors from other pediatric soft tissue tumors. Am J Surg Pathol (2004) 1.69
Pregnancy outcomes after abdominal irradiation that included or excluded the pelvis in childhood Wilms tumor survivors: a report from the National Wilms Tumor Study. Int J Radiat Oncol Biol Phys (2004) 1.65
Comparison of alignment software for genome-wide bisulphite sequence data. Nucleic Acids Res (2012) 1.45
Three linked vasculopathic processes characterize Kawasaki disease: a light and transmission electron microscopic study. PLoS One (2012) 1.45
Rhabdoid tumor of the kidney in the National Wilms' Tumor Study: age at diagnosis as a prognostic factor. J Clin Oncol (2005) 1.45
Renal medullary carcinoma: clinical, pathologic, immunohistochemical, and genetic analysis with pathogenetic implications. Urology (2002) 1.44
Treatment of metastatic Ewing sarcoma/primitive neuroectodermal tumor of bone: evaluation of increasing the dose intensity of chemotherapy--a report from the Children's Oncology Group. Pediatr Blood Cancer (2007) 1.43
Treatment of metastatic Ewing's sarcoma or primitive neuroectodermal tumor of bone: evaluation of combination ifosfamide and etoposide--a Children's Cancer Group and Pediatric Oncology Group study. J Clin Oncol (2004) 1.37
High telomerase RNA expression level is an adverse prognostic factor for favorable-histology Wilms' tumor. J Clin Oncol (2005) 1.35
Children's Oncology Group's 2013 blueprint for research: renal tumors. Pediatr Blood Cancer (2012) 1.32
Intensive therapy with growth factor support for patients with Ewing tumor metastatic at diagnosis: Pediatric Oncology Group/Children's Cancer Group Phase II Study 9457--a report from the Children's Oncology Group. J Clin Oncol (2006) 1.30
Management of Wilms' tumour: current practice and future goals. Lancet Oncol (2004) 1.28
Long-term outcomes for infants with very low risk Wilms tumor treated with surgery alone in National Wilms Tumor Study-5. Ann Surg (2010) 1.28
Could epigenetics play a role in the developmental origins of health and disease? Pediatr Res (2007) 1.26
Intraoperative spillage of favorable histology wilms tumor cells: influence of irradiation and chemotherapy regimens on abdominal recurrence. A report from the National Wilms Tumor Study Group. Int J Radiat Oncol Biol Phys (2010) 1.20
Clinically relevant subsets identified by gene expression patterns support a revised ontogenic model of Wilms tumor: a Children's Oncology Group Study. Neoplasia (2012) 1.19
Doxorubicin for favorable histology, Stage II-III Wilms tumor: results from the National Wilms Tumor Studies. Cancer (2004) 1.19
Clear cell sarcoma of the kidney: up-regulation of neural markers with activation of the sonic hedgehog and Akt pathways. Clin Cancer Res (2005) 1.18
Pregnancy outcome after treatment for Wilms tumor: a report from the national Wilms tumor long-term follow-up study. J Clin Oncol (2010) 1.16
Destabilized adhesion in the gastric proliferative zone and c-Src kinase activation mark the development of early diffuse gastric cancer. Cancer Res (2007) 1.15
Influence of radiation therapy delay on abdominal tumor recurrence in patients with favorable histology Wilms' tumor treated on NWTS-3 and NWTS-4: a report from the National Wilms' Tumor Study Group. Int J Radiat Oncol Biol Phys (2003) 1.14
Bilateral Wilms' tumors with progressive or nonresponsive disease. J Pediatr Surg (2006) 1.14
Ewing sarcoma/primitive neuroectodermal tumor of the chest wall: impact of initial versus delayed resection on tumor margins, survival, and use of radiation therapy. Ann Surg (2003) 1.14
Ultrastructural, immunofluorescence, and RNA evidence support the hypothesis of a "new" virus associated with Kawasaki disease. J Infect Dis (2011) 1.12
Early and late mortality after diagnosis of wilms tumor. J Clin Oncol (2009) 1.12
Rhabdoid tumor: gene expression clues to pathogenesis and potential therapeutic targets. Lab Invest (2010) 1.11
Treatment of Wilms tumor relapsing after initial treatment with vincristine, actinomycin D, and doxorubicin. A report from the National Wilms Tumor Study Group. Pediatr Blood Cancer (2008) 1.11
Characteristics and outcomes of children with the Wilms tumor-Aniridia syndrome: a report from the National Wilms Tumor Study Group. J Clin Oncol (2003) 1.11
Characterization of loss-of-inactive X in Klinefelter syndrome and female-derived cancer cells. Oncogene (2004) 1.11
Sequential WT1 and CTNNB1 mutations and alterations of beta-catenin localisation in intralobar nephrogenic rests and associated Wilms tumours: two case studies. J Clin Pathol (2006) 1.11
hTERT gene amplification and increased mRNA expression in central nervous system embryonal tumors. Am J Pathol (2003) 1.11
RANBP2 and CLTC are involved in ALK rearrangements in inflammatory myofibroblastic tumors. Cancer Genet Cytogenet (2007) 1.10
CITED1 expression in Wilms' tumor and embryonic kidney. Neoplasia (2007) 1.10
The imprinted gene and parent-of-origin effect database now includes parental origin of de novo mutations. Nucleic Acids Res (2006) 1.10
Effect of duration of treatment on treatment outcome for patients with clear-cell sarcoma of the kidney: a report from the National Wilms' Tumor Study Group. J Clin Oncol (2004) 1.09
The roles of supernumerical X chromosomes and XIST expression in testicular germ cell tumors. J Urol (2003) 1.08
Comparative genomic hybridization detects an increased number of chromosomal alterations in large cell/anaplastic medulloblastomas. Brain Pathol (2002) 1.08
A gene expression signature for relapse of primary wilms tumors. Cancer Res (2005) 1.07
Pancreatoblastoma is associated with chromosome 11p loss of heterozygosity and IGF2 overexpression. Med Pediatr Oncol (2002) 1.07
Treatment of Wilms tumor relapsing after initial treatment with vincristine and actinomycin D: a report from the National Wilms Tumor Study Group. Pediatr Blood Cancer (2007) 1.05
Risk factors for end stage renal disease in non-WT1-syndromic Wilms tumor. J Urol (2011) 1.05
Renal medullary carcinoma and ABL gene amplification. J Urol (2005) 1.05
Bilateral Wilms' tumor with anaplasia: lessons from the National Wilms' Tumor Study. J Pediatr Surg (2006) 1.05
Technical considerations for reduced representation bisulfite sequencing with multiplexed libraries. J Biomed Biotechnol (2012) 1.04
Clinicopathologic findings predictive of relapse in children with stage III favorable-histology Wilms tumor. J Clin Oncol (2013) 1.04
Mapping the zebrafish brain methylome using reduced representation bisulfite sequencing. Epigenetics (2013) 1.02
Silencing of MYCN by RNA interference induces growth inhibition, apoptotic activity and cell differentiation in a neuroblastoma cell line with MYCN amplification. Int J Oncol (2007) 1.01
Molecular profiling reveals frequent gain of MYCN and anaplasia-specific loss of 4q and 14q in Wilms tumor. Genes Chromosomes Cancer (2011) 1.01
Primary synovial sarcoma of the kidney diagnosed by molecular detection of SYT-SSX fusion transcripts. J Urol (2002) 1.00
IGF2/H19 imprinting analysis of human germ cell tumors (GCTs) using the methylation-sensitive single-nucleotide primer extension method reflects the origin of GCTs in different stages of primordial germ cell development. Genes Chromosomes Cancer (2005) 1.00
In vitro RNA interference against beta-catenin inhibits the proliferation of pediatric hepatic tumors. Int J Oncol (2006) 1.00
Molecular genetic analysis of central nervous system germ cell tumors with comparative genomic hybridization. Mod Pathol (2006) 0.99
Pulmonary disease after treatment for Wilms tumor: a report from the national wilms tumor long-term follow-up study. Pediatr Blood Cancer (2013) 0.96
Targeting the apoptosome for cancer therapy. Clin Cancer Res (2009) 0.96
Predicting relapse in favorable histology Wilms tumor using gene expression analysis: a report from the Renal Tumor Committee of the Children's Oncology Group. Clin Cancer Res (2009) 0.96
Methylation-associated silencing of the heat shock protein 47 gene in human neuroblastoma. Cancer Res (2004) 0.96
Immunohistochemistry of primary malignant neuroepithelial tumors of the kidney: a potential source of confusion? A study of 30 cases from the National Wilms Tumor Study Pathology Center. Hum Pathol (2006) 0.95
β-Catenin and K-RAS synergize to form primitive renal epithelial tumors with features of epithelial Wilms' tumors. Am J Pathol (2011) 0.94
Portal hypertension in children with Wilms' tumor: a report from the National Wilms' Tumor Study Group. Int J Radiat Oncol Biol Phys (2009) 0.93